drugset / Trial / NCT02768649
Single Ascending Dose Study of RBP-7000
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study was to assess the safety and tolerability of injections of RBP-7000 in subjects with stable schizophrenia
Timeline
- Start
- 2011-04
- Primary completion
- 2012-02
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Risperidone | Other / unclassified | — | Subcutaneous |
| Background | Risperidone | Other / unclassified | 0.25 mg | Oral |